Valmark Advisers, Inc. Amgen Inc Transaction History

Valmark Advisers, Inc.

$6.34 Billion
Q3 2024

A detailed history of Valmark Advisers, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Valmark Advisers, Inc. holds 8,498 shares of AMGN stock, worth $2.25 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

8,498

Previous 8,609 1.29%

Holding current value

$2.25 Million

Previous $2.69 Million 1.82%

% of portfolio

0.04%

Previous 0.05%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$309.38 - $337.38 $34,341 - $37,449	-111 Reduced 1.29%	8,498 $2.74 Million
Q2 2024 Jul 31, 2024	BUY	$262.75 - $319.31 $7,094 - $8,621	27 Added 0.31%	8,609 $2.69 Million
Q1 2024 May 03, 2024	BUY	$268.87 - $324.56 $146,803 - $177,209	546 Added 6.79%	8,582 $2.44 Million
Q4 2023 Feb 02, 2024	BUY	$255.7 - $288.46 $11,506 - $12,980	45 Added 0.56%	8,036 $2.31 Million
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $5,247 - $6,515	24 Added 0.3%	7,991 $2.15 Million
Q2 2023 Aug 02, 2023	SELL	$214.27 - $253.37 $13,284 - $15,708	-62 Reduced 0.77%	7,967 $1.77 Million
Q1 2023 May 01, 2023	BUY	$225.79 - $275.2 $51,028 - $62,195	226 Added 2.9%	8,029 $1.94 Million
Q4 2022 Feb 06, 2023	BUY	$229.03 - $291.01 $114,285 - $145,213	499 Added 6.83%	7,803 $2.05 Million
Q3 2022 Nov 02, 2022	BUY	$224.46 - $253.15 $3,591 - $4,050	16 Added 0.22%	7,304 $1.65 Million
Q2 2022 Aug 01, 2022	BUY	$230.71 - $256.74 $9,228 - $10,269	40 Added 0.55%	7,288 $1.77 Million
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $75,867 - $83,929	346 Added 5.01%	7,248 $1.75 Million
Q4 2021 Feb 02, 2022	SELL	$198.88 - $227.6 $48,128 - $55,079	-242 Reduced 3.39%	6,902 $1.55 Million
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $11,250 - $13,181	-53 Reduced 0.74%	7,144 $1.52 Million
Q2 2021 Aug 06, 2021	BUY	$233.58 - $259.14 $38,307 - $42,498	164 Added 2.33%	7,197 $1.75 Million
Q1 2021 May 04, 2021	BUY	$221.91 - $258.6 $104,963 - $122,317	473 Added 7.21%	7,033 $1.75 Million
Q4 2020 Feb 03, 2021	BUY	$216.38 - $257.67 $1.2 Million - $1.43 Million	5,540 Added 543.14%	6,560 $1.51 Million
Q3 2020 Nov 09, 2020	SELL	$234.65 - $260.95 $1,877 - $2,087	-8 Reduced 0.78%	1,020 $259,000
Q2 2020 Jul 31, 2020	SELL	$197.81 - $242.74 $7,318 - $8,981	-37 Reduced 3.47%	1,028 $242,000
Q1 2020 May 01, 2020	SELL	$182.24 - $241.7 $7,107 - $9,426	-39 Reduced 3.53%	1,065 $216,000
Q4 2019 Jan 31, 2020	SELL	$189.21 - $243.2 $28,570 - $36,723	-151 Reduced 12.03%	1,104 $266,000
Q3 2019 Nov 06, 2019	BUY	$174.11 - $208.62 $29,598 - $35,465	170 Added 15.67%	1,255 $243,000
Q2 2019 Aug 07, 2019	SELL	$166.7 - $195.41 $4,000 - $4,689	-24 Reduced 2.16%	1,085 $200,000
Q2 2018 Aug 07, 2018	BUY	$166.05 - $186.51 $184,149 - $206,839	1,109 New	1,109 $205,000
Q1 2018 May 07, 2018	SELL	$169.43 - $198.0 $198,910 - $232,452	-1,174 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $198,159 - $221,404	1,174	1,174 $204,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valmark Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Valmark Advisers, Inc. with notifications on news.

Account

Valmark Advisers, Inc. Amgen Inc Transaction History